PhRMA encouraged by number of HIV therapies in development
92 new products in development for HIV/AIDS
A report recently released by PhRMA said 92 medicines and vaccines are currently under development for the prevention and treatment of HIV/AIDS. Of those, 20 are vaccines and 46 are antivirals that are either in clinical trials or are under review by the FDA. The report also lists 30 drugs that have been approved since the virus first reared its ugly head more than 20 years ago. According to the report, there are an estimated 33.2 million people living with HIV worldwide. The report can be accessed on-line at
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
